David Smadja: Truly Honored to Join as a Co-Chair of the SSC Subcommittee on Biorheology, Biomaterials, and Bioengineering of ISTH
David Smadja, Professor of Hematology (PU-PH) at University of Paris Cité, European Georges Pompidou Hospital, shared on LinkedIn:
”I’m truly honored to join as a Co-Chair of the SSC Subcommittee on Biorheology, Biomaterials, and Bioengineering of International Society on Thrombosis and Haemostasis (ISTH)
This Subcommittee brings together scientists and clinicians from across the world to explore how biomaterials, flow mechanics, and vascular biology intersect — advancing both our understanding and clinical innovation in thrombosis and hemostasis.
Grateful to the ISTH community for the trust and to all colleagues contributing to this inspiring collective effort.”
Find more on ISTH Biorheology, Biomaterials, and Bioengineering subcommittee here.
Stay updated with Hemostasis Today.
-
Jan 12, 2026, 14:46A Behcet Disease with Aortic Thrombosis: Alexandru Stieber Shares A Peculiar Case
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies